FOLLICULAR LYMPHOMA FOUNDATION
OUR MISSION IS TO HELP THOSE WITH FOLLICULAR LYMPHOMA (FL), A CURRENTLY INCURABLE BLOOD CANCER, TO LIVE WELL AND GET WELL BY FINDING AND FUNDING THE BEST RESEARCH TO FIND BREAKTHROUGHS THAT WILL CHANGE HOW WE UNDERSTAND AND TREAT FL. WE PROVIDE FL FOCUSED INFORMATION RESOURCES FOR PATIENTS AND WORK TO ENSURE PATIENTS' VOICES ARE AT THE HEART OF THE SEARCH FOR BETTER TREATMENTS AND CURE.
Objects
THE CHARITY'S OBJECTS (‘OBJECTS’) ARE SPECIFICALLY RESTRICTED TO THE FOLLOWING:(1) TO PROTECT AND PRESERVE PUBLIC HEALTH AND PROVIDE RELIEF FOR THOSE WHO ARE AFFECTED BY FOLLICULAR LYMPHOMA (FL) INCLUDING PATIENTS, THEIR FAMILIES AND CARERS, IN PARTICULAR BUT NOT EXCLUSIVELY BY:A) THE PROMOTION OF RESEARCH INTO THE NATURE, CAUSES, DIAGNOSIS, PREVENTION, TREATMENT AND CURE OF FL WHICH LEADS TO BETTER DIAGNOSIS, TREATMENT AND OUTCOMES FOR FL PATIENTS INCLUDING THE DEVELOPMENT OF FINDINGS OF RESEARCH INTO PRACTICAL APPLICATIONS FOR THE PREVENTION, TREATMENT AND CURE OF FL AND DISSEMINATION OF THE RESULTS OF ANY SUCH RESEARCH FOR THE BENEFIT OF THE PUBLIC;B) PROVIDING OR ASSISTING IN THE PROVISION OF INFORMATION ABOUT FL DIRECTLY TO THOSE AFFECTED BY THE DISEASE;C) RAISING PUBLIC AWARENESS ABOUT FL, ITS CAUSES, DIAGNOSIS, PREVENTION AND TREATMENT.
Financial health, per its FY2025 accounts
The charity reported a surplus of £47,078 for the year ended 31 December 2025, with total funds increasing to £1,286,694. The trustees confirmed that free reserves of £1,021,409 exceed the stated policy target of approximately three months of planned expenditure. The accounts were prepared on a going concern basis, supported by an approved business plan to December 2027 and adequate cash resources.
What the accounts disclose
“In the band £240,001 - £250,000 1 -” — page 32
“In the band £90,001 - £100,000 ; : 4 2 In the band £220,001 - £230,000 - 1 In the band £240,001 - £250,000 1 -” — page 32
“The Trustees have determined that free reserves should be maintained at a level equivalent to approximately three months of planned expenditure.” — page 12
“During the year, the charity recharged £89,212 of shared costs to Follicular Lymphoma Foundation US, recognised as other income in note 5.” — page 38
“The charity received donations totalling £27,750 (2024: £nil) from entities controlled by trustees, and £82,750 (2024: £84,000) of unrestricted donations from trustees (see note 11).” — page 38
“During the year, the charity recharged £89,212 of shared costs to Follicular Lymphoma Foundation US, recognised as other income in note 5.” — page 38
“The charity received donations totalling £27,750 (2024: £nil) from entities controlled by trustees, and £82,750 (2024: £84,000) of unrestricted donations from trustees (see note 11).” — page 38
“During the year, the charity recharged £89,212 of shared costs to Follicular Lymphoma Foundation US, recognised as other income in note 5.” — page 38
“The charity received donations totalling £27,750 (2024: £nil) from entities controlled by trustees, and £82,750 (2024: £84,000) of unrestricted donations from trustees (see note 11).” — page 38
Year-over-year changes
- Top pay band moved from £80,001 - £90,000 (FY2024) to £240,001 - £250,000 (FY2025).
Policies the charity declares
- Bullying and harassment policy and procedures
- Complaints handling
- Complaints policy and procedures
- Conflicting interests
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Safeguarding policy and procedures
- Serious incident reporting policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/12/2025
- Employees paid over £60,000: 3 (£70,001–£80,000: 1; £90,001–£100,000: 1; £200,001–£250,000: 1)
- Trustee benefits, answered Yes to: any trustee benefit; payments to trustees for services to the charity
Self-declared on the annual return for the financial year ending 31/12/2024
- Volunteers: 2
- Employees paid over £60,000: 4 (£60,001–£70,000: 1; £80,001–£90,000: 1; £90,001–£100,000: 1; £200,001–£250,000: 1)
Self-declared on the annual return for the financial year ending 31/12/2023
- Employees paid over £60,000: 4 (£60,001–£70,000: 1; £80,001–£90,000: 1; £90,001–£100,000: 1; £200,001–£250,000: 1)
Leadership, per the charity’s website
- Emma France — Global Chief Executive Officer
- Nicola Mendelsohn — Chair, UK and US Board
- Lord Jon Mendelsohn — UK and US Board
- Lord Richard Harrington — UK Board
- Andrea Wong — UK Board
- Mike Thompson — UK Board
- Professor Jonathan Simons — UK and US Board
- Jess Burley — UK Board
Structured financials (annual return, FY ending 31/12/2025)
Trustees
- Lady Nicola Sharon Mendelsohnchair
- Andrea Lynn Wong
- Jessica Jane Burley
- Jonathan Wilson Simons
- Lord Richard Irwin Harrington
- PETER MICHAEL VARDEY THOMPSON
- The Lord Jonathan Neil Mendelsohn
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2025 | £2.5m | £2.5m |
| 31/12/2024 | £2.4m | £2.4m |
| 31/12/2023 | £2.1m | £2.0m |
| 31/12/2022 | £2.2m | £2.4m |
| 31/12/2021 | £1.7m | £636k |
Common questions
Is FOLLICULAR LYMPHOMA FOUNDATION financially healthy?
Per its FY2025 accounts: The charity reported a surplus of £47,078 for the year ended 31 December 2025, with total funds increasing to £1,286,694. The trustees confirmed that free reserves of £1,021,409 exceed the stated policy target of approximately three months of planned expenditure. The accounts were prepared on a going concern basis, supported by an approved business plan to December 2027 and adequate cash resources. Its FY2025 accounts were audited by Cooper Parry Group Limited.
What does the highest-paid employee of FOLLICULAR LYMPHOMA FOUNDATION earn?
Per its FY2025 accounts, the highest-paid employee was in the £240,001 - £250,000 band, and 2 employees earned over £60,000.
Who funds FOLLICULAR LYMPHOMA FOUNDATION?
Funders whose own accounts filings name FOLLICULAR LYMPHOMA FOUNDATION as a grant recipient include THE MAURICE WOHL CHARITABLE FOUNDATION, THE CHARLES WOLFSON CHARITABLE TRUST, Blood Cancer UK Research, THE ERANDA ROTHSCHILD FOUNDATION, THE BENSON AND LIONEL BLACK CHARITABLE TRUST.
Shared trustees with funders
- The Lord Jonathan Neil Mendelsohn — trustee here and at THE CHARLES WOLFSON CHARITABLE TRUST
Known funders
| Funder | Year | Amount | Purpose (as stated by the funder) |
|---|---|---|---|
| THE MAURICE WOHL CHARITABLE FOUNDATION | FY2022 | £400k | Medical Advancement |
| THE MAURICE WOHL CHARITABLE FOUNDATION | FY2021 | £400k | Medical Advancement |
| THE CHARLES WOLFSON CHARITABLE TRUST | FY2024 | £150k | Medicine |
| THE CHARLES WOLFSON CHARITABLE TRUST | FY2025 | £150k | Medicine |
| THE CHARLES WOLFSON CHARITABLE TRUST | FY2022 | £125k | Medicine |
| Blood Cancer UK Research | FY2024 | £87k | Research co-funding agreement |
| THE ERANDA ROTHSCHILD FOUNDATION | FY2022 | £50k | Health/welfare/medical research |
| THE BENSON AND LIONEL BLACK CHARITABLE TRUST | FY2023 | £50k | |
| THE REGATTA FOUNDATION | FY2022 | £50k | |
| THE REGATTA FOUNDATION | FY2025 | £50k | |
| THE UKI CHARITABLE FOUNDATION | FY2023 | £38k | |
| THE ERANDA ROTHSCHILD FOUNDATION | FY2023 | £20k | Health/welfare/medical research |
| THE JMCMRJ SORRELL FOUNDATION | FY2021 | £5k | poverty alleviation and health improvement |
| RECHOV GORDON CHARITABLE TRUST | FY2022 | £3k | |
| RECHOV GORDON CHARITABLE TRUST | FY2024 | £2k | relief of poverty, advancement of Jewish religion and advancement of Jewish religious education |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| The Trillium Trust UK | 1 | £50k |
| THE PENNIES FOUNDATION | 1 | £44k |
| THE 29TH MAY 1961 CHARITY | 1 | £30k |
| BNA CHARITABLE INCORPORATED ORGANISATION | 1 | £25k |
| THE SYNCONA FOUNDATION | 1 | £20k |
| THE DICKINSON FAMILY CHARITABLE TRUST | 1 | £16k |
| THE ROAN CHARITABLE TRUST | 1 | £15k |
| Reece Family Trust | 1 | £10k |
Charities like this
- LYMPHOMA ACTION
- CURE LEUKAEMIA
- MELANOMA-ME FOUNDATION
- FULHAM FOOTBALL CLUB FOUNDATION
- THE FACULTY OF FORENSIC & LEGAL MEDICINE OF THE ROYAL COLLEGE OF PHYSICIANS
- THE UK CLL FORUM
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| FOLLICULAR LYMPHOMA FOUNDATION | £2.5m | £240,001 - £250,000 | 2 | unclear | — | no doubt |
| LYMPHOMA ACTION | £2.9m | — | — | unclear | — | no doubt |
| CURE LEUKAEMIA | £3.7m | — | — | unclear | — | no doubt |
| MELANOMA-ME FOUNDATION | £161k | — | 0 | above | — | no doubt |
| FULHAM FOOTBALL CLUB FOUNDATION | £2.9m | — | — | above | — | no doubt |
| THE FACULTY OF FORENSIC & LEGAL MEDICINE OF THE ROYAL COLLEGE OF PHYSICIANS | £1.0m | £60,000 - £69,999 | 1 | unclear | — | no doubt |